NCT02403713View on ClinicalTrials.gov

A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

September 30, 2015

Conditions
Asthma
Interventions
DRUG

Fluticasone/formoterol BAI

Fluticasone/formoterol 125/5 µg breath actuated inhaler (BAI) (250/10 µg total dose)

DRUG

Formoterol

Formoterol

DRUG

Fluticasone/formoterol PMDI without spacer

Fluticasone/Formoteral 125/5µg pMDI without spacer

DRUG

Fluticasone/formoterol PMDI with spacer

Fluticasone/Formoteral 125/5µg pMDI with spacer

DRUG

Fluticasone/formoterol PMDI without spacer low dose

Fluticasone/Formoteral 125/5µg pMDI without spacer, low dose

Trial Locations (1)

Unknown

Belfast

All Listed Sponsors
lead

Mundipharma Research Limited

INDUSTRY

NCT02403713 - A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter